For the first time in over 20 years, Americans are about to have access to a sunscreen ingredient that the rest of the world has trusted for decades. On June 9, 2026, the U.S. Food and Drug Administration officially approved bemotrizinol - also known by its brand name PARSOL Shield - as a permitted active ingredient in over-the-counter sunscreens. This is not just a regulatory update. It is a meaningful shift in how well Americans can protect their skin from one of the most well-documented environmental threats to human health: ultraviolet radiation.
If you have ever wondered why sunscreens from Japan, Korea, France, or Australia feel lighter, absorb faster, and seem to work better, the answer lies partly in this exact gap - a regulatory bottleneck that kept superior UV filters off U.S. shelves for a generation. That gap is now closing, and understanding what it means for your skin is worth your full attention.
What Is Bemotrizinol and Why Does It Matter?
Bemotrizinol is a synthetic broad-spectrum UV filter - meaning it is chemically engineered to absorb and neutralize both UVA and UVB radiation simultaneously. UVB rays are the primary cause of sunburn, while UVA rays penetrate more deeply into the dermis and are responsible for premature aging, pigmentation changes, DNA damage, and a significant share of skin cancer risk. Most chemical UV filters currently permitted in the United States provide strong UVB coverage but inadequate UVA protection - a structural weakness that bemotrizinol directly addresses.
The ingredient was first developed in the late 1990s by Switzerland-based Ciba Specialty Chemicals and was adopted into European sunscreen formulations by the year 2000. Canada and multiple Asian countries followed shortly after. For the past two decades, millions of people across these regions have applied bemotrizinol to their skin daily. The safety and efficacy data that has accumulated is, by any measure, substantial. What changed in the United States is not the science - it is the regulatory framework that finally allowed that science to be recognized.
Why It Took 25 Years to Reach the U.S.
The delay is not a story of scientific doubt. The U.S. regulates sunscreens as over-the-counter drugs, unlike most other countries where they are classified as cosmetics. This means every new UV filter must clear the same evidentiary bar as a pharmaceutical compound - a process that requires enormous investment and years of submissions, reviews, and public comment periods. DSM Nutritional Products LLC, the company that brought the formal application, spent over 20 years navigating this process before finally receiving FDA approval. The CARES Act introduced a streamlined OTC monograph review process, and bemotrizinol is the first new sunscreen ingredient to benefit from it - with the FDA finalizing its decision within just seven months of its December 2025 proposed order.
The FDA's Acting Director of the Center for Drug Evaluation and Research, Dr. Mike Davis, stated that this outcome demonstrates what becomes possible when regulatory processes are modernized and sound science is applied to decision-making.
The UVA Gap: A Problem Most People Do Not Know They Have
Here is the problem that makes this approval so consequential. Research has shown that most sunscreens sold in the United States provide only about one-quarter of the UVA protection that their SPF labels might lead consumers to expect. SPF measures protection against UVB rays - the rays that cause sunburn - but says very little about UVA shielding. European sunscreen regulations require much higher UVA standards relative to UVB, which is why European-formulated products have historically offered more complete photoprotection.
UVA rays make up approximately 95% of the ultraviolet radiation that reaches the Earth's surface. They penetrate clouds and glass, are present throughout daylight hours year-round, and go deep enough to damage collagen fibers, elastin, and the DNA of skin cells in the deeper dermal layers. Long-term UVA exposure is strongly associated with squamous cell carcinoma and melanoma, as well as the photoaging changes - wrinkles, pigmentation, and loss of skin elasticity - that accumulate invisibly for decades before becoming visible. The visible sunburn from UVB is, in a sense, the body's alarm system. The silent damage from UVA has no equivalent alarm.
This is precisely why dermatologists and public health researchers have long argued that America's sunscreen options were leaving a dangerous protection gap - and why the approval of a superior broad-spectrum filter like bemotrizinol has been described by dermatologists as hitting "really every box" for what they have been waiting for.
The Current U.S. Sunscreen Landscape - and Its Limitations
Before bemotrizinol, the two most widely used options for UVA protection in American sunscreens were avobenzone and zinc oxide, each with meaningful drawbacks.
Avobenzone is photounstable - it degrades when exposed to sunlight, reducing its protective capacity over time and requiring stabilizing agents that add formulation complexity. Zinc oxide, while effective and photostable, leaves a white cast on the skin that many users find cosmetically unacceptable, which directly reduces compliance - especially among darker skin tones.
Some existing chemical UV filters have also raised concerns about systemic absorption, with studies showing that certain compounds like oxybenzone can enter the bloodstream and have been detected in breast milk. Bemotrizinol does not share this profile. As noted by Dr. Steven Wang, chief of dermatology at Hoag Memorial Hospital Presbyterian, bemotrizinol does not penetrate the body surface and does not absorb into the bloodstream, giving it a favorable safety profile compared to many currently approved chemical filters.
What Makes Bemotrizinol Different: The Science
Superior UVA Coverage and Photostability
Bemotrizinol provides protection across the full UVA spectrum - both UVA1 (340-400nm) and UVA2 (320-340nm) - as well as UVB rays (280-315nm). This full-spectrum coverage is rare among approved U.S. chemical filters. Just as importantly, bemotrizinol is photostable - it does not degrade under sun exposure the way avobenzone does, meaning it maintains its protective capacity throughout actual outdoor exposure.
Low Skin Penetration and Favorable Tolerability
The FDA's review classified bemotrizinol as Generally Recognized as Safe and Effective (GRASE) for use in adults and children six months of age and older, at concentrations up to 6%. The compound's large molecular size limits its ability to cross the skin barrier, which addresses one of the primary safety concerns surrounding chemical sunscreen filters. Dr. Adam Friedman, chair of dermatology at the GW School of Medicine, noted that existing chemical UV filters are irritating at baseline, particularly for those with acne, rosacea, or eczema, and that bemotrizinol appears to be better tolerated in comparison. For the millions of Americans with sensitive or reactive skin who struggle with sunscreen adherence, this represents a practical improvement.
Cosmetically Elegant Formulation
One of the least discussed but clinically significant barriers to sunscreen use is cosmetic acceptability. Sunscreen that feels heavy, leaves a white cast, or causes stinging significantly reduces how consistently people actually use it - and inconsistent use undermines protection far more than ingredient formulation differences. Bemotrizinol is water-resistant, has a light texture, and does not produce the white cast associated with mineral filters. European and Asian consumers have benefited from these properties for over two decades, and products featuring bemotrizinol are expected to reach American shelves by the end of 2026.
Skin Cancer - The Urgent Backdrop to This Approval
The regulatory approval of bemotrizinol comes against a deeply concerning epidemiological backdrop. Skin cancer is the most commonly diagnosed cancer in the United States, with more new cases diagnosed each year than all other cancers combined. One in five Americans will develop skin cancer by the age of 70, and more than two people die from the disease every hour. Melanoma, the most deadly form, has seen rising incidence particularly among young adults, with rates in women under 40 increasing faster than in almost any other demographic.
UV radiation is the primary preventable risk factor for skin cancer, and sunscreen is one of the most studied and consistently supported interventions in dermatology. But sunscreen only works when people use it correctly - which requires products that are cosmetically tolerable, effective across the full UV spectrum, and stable under real-world conditions. Bemotrizinol improves on all three fronts.
For those managing conditions where chronic inflammation plays a role - including inflammatory skin disorders, autoimmune skin conditions, and UV-aggravated conditions like lupus - the introduction of a more effective and better-tolerated sunscreen filter has direct clinical relevance. Find out more about how natural ingredients support inflammation management in the Natural Ingredients library at Naturem.
How the Rest of the World Has Been Doing It Better
The FDA's approval of bemotrizinol brings the total number of permitted sunscreen active ingredients in the United States to 17. Europe, by comparison, has more than 30 approved UV filters, many of which have been available to consumers for 10 to 25 years. This regulatory asymmetry has had real public health consequences. It has also created a culturally significant phenomenon: the growth of a large, sophisticated online community of U.S. consumers who specifically import European and Asian sunscreens to access superior formulations.
South Korean and Japanese sunscreen formulations in particular have developed a near-cult following for their elegant textures, high UVA protection ratings, and photostability - all properties that are easier to achieve when formulators have access to a wider palette of approved UV filters. Mexoryl 400, another highly effective UVA filter widely used in Asian sunscreen formulations, is anticipated by experts to follow bemotrizinol into the U.S. approval pipeline, continuing the regulatory catch-up.
The EU's classification of sunscreens as cosmetics has allowed a faster innovation cycle. As formulation scientists gained access to newer filters, they could develop products that consumers were far more willing to use daily - an outcome that has measurable public health value.
The Role of Natural Antioxidants in Complementing Sun Protection
Sun protection is not solely a matter of what you apply to your skin - it is also about what happens inside your skin cells when UV radiation strikes. Research published in the journal Photochemical and Photobiological Sciences confirms that dietary antioxidants - including carotenoids, vitamins C and E, and polyphenols - contribute to endogenous photoprotection by scavenging the reactive oxygen species generated by UV exposure.
When UV rays penetrate the skin, they generate free radicals that damage lipids, proteins, and DNA. Topical sunscreens reduce the amount of UV radiation reaching skin cells, but the radiation that does penetrate still triggers oxidative cascades. This is where nutritional photoprotection becomes relevant as a complementary layer of defense rather than a replacement for sunscreen.
Hydroxytyrosol, a polyphenol derived from olive oil and olive leaves, is among the most potently studied natural antioxidants for skin protection. Research has demonstrated that hydroxytyrosol is capable of neutralizing free radicals, reducing UV-induced inflammatory signaling, and supporting skin barrier integrity through its effects on ceramide synthesis and lipid production. Find out more about how hydroxytyrosol works at the cellular level in this dedicated article on Hydroxytyrosol and skincare at Naturem.
Key Natural Ingredients That Support Skin's UV Defense
Several well-researched natural compounds work in concert with topical sun protection to reduce cumulative photodamage:
Understanding how these internal mechanisms work alongside external sunscreen use can help you build a more comprehensive, layered approach to skin health and aging prevention.
What This Means for Consumers: A Practical Guide
When Will Bemotrizinol Products Be Available?
Products featuring bemotrizinol are expected to reach U.S. retail shelves by the end of 2026, with broader availability projected into 2027 as manufacturers reformulate existing products and develop new ones. The FDA approval allows bemotrizinol to be used at concentrations up to 6% in sunscreen formulations, alone or in combination with other permitted active ingredients.
How to Read the Emerging Sunscreen Labels
When bemotrizinol products become available, look for:
The Correct Way to Apply Sunscreen - Which Matters More Than the Ingredient
Even the most advanced UV filter fails if the product is not applied correctly. Studies consistently show that most people apply only 25-50% of the recommended amount of sunscreen, reducing real-world protection by a factor of 2 to 4. The standard guidance is:
- Apply one ounce (roughly a full shot glass) to cover the entire body
- Apply 15-30 minutes before sun exposure to allow the filter to bind to the skin
- Reapply every two hours, and immediately after swimming or heavy sweating
- Cover commonly missed areas: ears, back of the neck, tops of feet, and the dorsal surface of hands
Daily sunscreen use - not just on beach days - is the single most impactful behavioral choice for reducing lifetime skin cancer risk and visible photoaging.
Dermatologists Respond: Why the Medical Community Is Celebrating
The reaction among dermatologists has been notably enthusiastic. Dr. Mona Gohara, a clinical professor of dermatology at Yale School of Medicine, described bemotrizinol as a highly effective, broad-spectrum UV filter that has been used safely in Europe, Asia, and many other countries for over two decades, and framed the approval as very positive news. Susan Mayou, a consultant dermatologist at the Cadogan Clinic in the UK, emphasized that the approval is particularly important because it closes the UVA protection gap that has left American skin particularly vulnerable to the deeper, cumulative DNA damage that drives premature aging and cancer risk.
The Personal Care Products Council, which represents sunscreen manufacturers, called the approval a significant advancement - and the competitive implications are real. Broader ingredient access means manufacturers can develop more cosmetically elegant products, which should improve consumer compliance, which in turn has direct public health benefits.
What Comes Next in U.S. Sunscreen Innovation
Bemotrizinol's approval is the first step in a long-overdue modernization process. The FDA has signaled through the MAHA Strategy Report a commitment to improving regulatory processes for over-the-counter sunscreens, which it acknowledges have fallen behind other countries. This suggests a more receptive environment for future applications.
Mexoryl 400, an organic UVA filter with excellent spectral coverage increasingly used in Asian and European formulations, is expected to be the next candidate for U.S. review. Additional filters, including tinosorb M and tinosorb S, which offer distinct photostability and spectral coverage profiles, remain in the pipeline. Each approval would give formulators more tools to build products that perform better, feel better, and get used more consistently.
For those who have spent years importing sunscreens from abroad or building elaborate skincare routines around limited domestic options, this regulatory shift represents a fundamental improvement in accessible skin health. For everyone else - particularly those who do not think often about sun protection beyond beach outings - it represents an opportunity to upgrade a habit that has lasting consequences for both appearance and health.
The science of UV protection has been clear for decades. The regulatory tools are now catching up. And for American consumers, that means better sunscreens, more choices, and - most importantly - healthier skin over a lifetime.
For guidance on natural ingredients that support skin health, inflammation management, and whole-body wellness from the inside out, explore the full Healthy Advice library at Naturem.
Frequently Asked Questions (FAQs)
1. What is bemotrizinol?
Bemotrizinol is a broad-spectrum sunscreen active ingredient that helps protect the skin from both UVA and UVB rays. It has been used in sunscreens in Europe and many other countries for years before receiving FDA approval in the United States. (FDA, 2026)
2. Why is FDA approval of bemotrizinol important?
This approval is important because it gives U.S. consumers access to a newer sunscreen filter that has long been available in other markets. Bemotrizinol may help improve broad-spectrum protection, especially against UVA rays, which are linked to premature aging and long-term skin damage. (FDA, 2026)
3. Is bemotrizinol considered safe?
The FDA considers bemotrizinol generally recognized as safe and effective, or GRASE, for use in sunscreens by adults and children 6 months of age and older. The approved concentration is up to 6% in over-the-counter sunscreen products. (FDA, 2026)
4. How is bemotrizinol different from older sunscreen filters?
Bemotrizinol is known for broad UVA and UVB coverage, low skin absorption, and strong photostability. These properties may help sunscreen formulas stay effective while also feeling lighter and more comfortable on the skin. (DSM-Firmenich, 2026)
5. Does this mean people can rely only on better sunscreen ingredients?
No. A better sunscreen ingredient can support protection, but correct use still matters. Dermatologists recommend applying sunscreen to all exposed skin and reapplying every two hours, especially after swimming or sweating. (AAD, 2025)
References
